
If you only glanced at the headlines on Hims & Hers Health, the story looked exciting. AI-native care, GLP-1 partnerships and global expansion sounded like the textbook setup for …
HIMS is down 0.43% today. Volume is 5.73M vs a 30-day average of 10.18M (0.56x).
Hims & Hers Health, Inc. is scheduled to report earnings Mon, Nov 9, 2026. Analysts expect EPS of $0.06 on revenue of about $910.75M. Stocks often move sharply on earnings day.

If you only glanced at the headlines on Hims & Hers Health, the story looked exciting. AI-native care, GLP-1 partnerships and global expansion sounded like the textbook setup for …

Hims & Hers Health (NYSE:HIMS) announced its largest men's health expansion with new injectable and oral testosterone replacement therapies. The fresh TRT offerings add personaliz…

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $27.71, marking a -4.87% move from the previous day.

Hims & Hers seeks dismissal of a consumer lawsuit, arguing upfront disclosures refute claims about user privacy, billing, and cancellations.

Hims & Hers Health (HIMS) asked a federal judge in California to toss out a Federal Trade Commission